In Part B of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added:
[Further details on identity and specification of active substance are provided in the review report.]
Common Name, Identification Numbers | IUPAC Name | Purity | Date of approval | Expiration of approval | Specific provisions
‘93 |
Mandestrobin
CAS No: 173662-97-0
CIPAC No: Not available
(RS)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide |
≥ 940 g/kg (on a dry weight basis)
Xylenes (ortho, meta, para), ethyl benzene max. 5 g/kg (TK)
9 December 2015 | 9 December 2025 |
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on mandestrobin, and in particular Appendices I and II thereof, shall be taken into account.
In this overall assessment Member States shall pay particular attention to:
the risk to aquatic organisms,
the protection of groundwater, when the substance is applied in regions with vulnerable soil and/or climatic conditions.
Conditions of use shall include risk mitigation measures, where appropriate.
The applicant shall submit confirmatory information as regards:
the technical specification of the active substance as manufactured (based on commercial scale production) including the relevance of some individual impurities;
the compliance of the toxicity batches with the confirmed technical specification.
The applicant shall submit that information to the Commission, the Member States and the Authority by 9 June 2016.’